Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xos (XOS) Gains from Investment Securities (2020 - 2025)

Historic Gains from Investment Securities for Xos (XOS) over the last 6 years, with Q3 2025 value amounting to -$1.7 million.

  • Xos' Gains from Investment Securities fell 41329.69% to -$1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$998000.0, marking a year-over-year decrease of 13625.14%. This contributed to the annual value of $2.7 million for FY2024, which is 15037.74% up from last year.
  • Latest data reveals that Xos reported Gains from Investment Securities of -$1.7 million as of Q3 2025, which was down 41329.69% from $548000.0 recorded in Q2 2025.
  • Over the past 5 years, Xos' Gains from Investment Securities peaked at $2.5 million during Q2 2024, and registered a low of -$1.7 million during Q3 2025.
  • Its 5-year average for Gains from Investment Securities is $152076.9, with a median of $133000.0 in 2023.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first skyrocketed by 1270000.0% in 2022, then plummeted by 41329.69% in 2025.
  • Quarter analysis of 5 years shows Xos' Gains from Investment Securities stood at $1000.0 in 2021, then skyrocketed by 12700.0% to $128000.0 in 2022, then rose by 3.91% to $133000.0 in 2023, then tumbled by 74.44% to $34000.0 in 2024, then plummeted by 5158.82% to -$1.7 million in 2025.
  • Its Gains from Investment Securities was -$1.7 million in Q3 2025, compared to $548000.0 in Q2 2025 and $140000.0 in Q1 2025.